Journal article
Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease
Experimental biology and medicine (Maywood, N.J.), Vol.242(2), pp.127-139
01/2017
DOI: 10.1177/1535370216669610
PMCID: PMC5167116
PMID: 27633573
Abstract
Sepsis is a poorly understood syndrome of systemic inflammation responsible for hundreds of thousands of deaths every year. The integrity of the gut epithelium and competence of adaptive immune responses are notoriously compromised during sepsis, and the prevalent assumption in the scientific and medical community is that intestinal commensals have a detrimental role in the systemic inflammation and susceptibility to nosocomial infections seen in critically ill, septic patients. However, breakthroughs in the last decade provide strong credence to the idea that our mucosal microbiome plays an essential role in adaptive immunity, where a human host and its prokaryotic colonists seem to exist in a carefully negotiated armistice with compromises and benefits that go both ways. In this review, we re-examine the notion that intestinal contents are the driving force of critical illness. An overview of the interaction between the microbiome and the immune system is provided, with a special focus on the impact of commensals in priming and the careful balance between normal intestinal flora and pathogenic organisms residing in the gut microbiome. Based on the data in hand, we hypothesize that sepsis induces imbalances in microbial populations residing in the gut, along with compromises in epithelial integrity. As a result, normal antigen sampling becomes impaired, and proliferative cues are intermixed with inhibitory signals. This situates the microbiome, the gut, and its complex immune network of cells and bacteria, at the center of aberrant immune responses during and after sepsis.
Details
- Title: Subtitle
- Enteric immunity, the gut microbiome, and sepsis: Rethinking the germ theory of disease
- Creators
- Javier Cabrera-Perez - University of MinnesotaVladimir P Badovinac - University of MinnesotaThomas S Griffith - University of Minnesota
- Resource Type
- Journal article
- Publication Details
- Experimental biology and medicine (Maywood, N.J.), Vol.242(2), pp.127-139
- DOI
- 10.1177/1535370216669610
- PMID
- 27633573
- PMCID
- PMC5167116
- NLM abbreviation
- Exp Biol Med (Maywood)
- ISSN
- 1535-3702
- eISSN
- 1535-3699
- Grant note
- R01 GM113961 / NIGMS NIH HHS I01 BX001324 / BLRD VA R01 AI114543 / NIAID NIH HHS R21 AI119160 / NIAID NIH HHS T32 AI007313 / NIAID NIH HHS R01 GM115462 / NIGMS NIH HHS
- Language
- English
- Date published
- 01/2017
- Academic Unit
- Microbiology and Immunology; Pathology
- Record Identifier
- 9984180921502771
Metrics
17 Record Views